Pathogenesis of neural tube defects: The story beyond methylation or one-carbon unit metabolism

Metabolomics

Volumn 8, Issue 5, 2012, Pages 919-929

  Liang, Xiaoping ^a,b   Wang, Yong ^a   Liang, Qiong Lin ^a   Wang, Yi Ming ^a   Huang, Min ^a,b   Luo, Guoan ^a,b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Biomarker; Metabolomics; Neural tube defects; UPLC TOF MS

Indexed keywords

DOCOSAHEXAENOIC ACID; FRUCTOSE 6 PHOSPHATE; LEUKOTRIENE; LINOLEIC ACID; LYSOPHOSPHATIDYLCHOLINE; PALMITIC ACID; PRASTERONE SULFATE; PSYCHOSINE; SPHINGOSINE 1 PHOSPHATE;

ADULT; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CARBON METABOLISM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METHYLATION; NEURAL TUBE DEFECT; PARTIAL LEAST SQUARES REGRESSION; PATTERN RECOGNITION; PREGNANCY; PRINCIPAL COMPONENT ANALYSIS; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 84867210740     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-011-0387-z     Document Type: Article

References (63)

1. Al, M. D., van Houwelingen, A. C., & Hornstra, G. (2000). Long-chain polyunsaturated fatty acids, pregnancy, and pregnancy outcome. American Journal of Clinical Nutrition, 71(1 suppl), 285S-291S.
2. Baker, R. S. P., Schopfer, J. F., Sweeney, S., & Freeman, A. B. (2004). Red cell membrane and plasma linoleic acid nitration products: synthesis, clinical identification, and quantitation. Proceedings of the National Academy of Sciences USA., 101, 11577-11582.
3. Bastianetto, S., Ramassamy, C., Poirier, J., & Quirion, R. (1999). Dehydroepiandrosterone-sulfate (DHEAS) protects hippocampal cells from oxidative stress-induced damage. Brain Research. Molecular Brain Research, 66, 35-41.
4. Baulieu, E. E. (1997). Neurosterioids: of the nervous system, by the nervous system, for the nervous system. Recent Progress in Hormone Research, 52, 1-32.
5. Berry, R. J., Li, Z., Erickson, J. D., Li, S., Moore, C. A., Wang, H., et al. (1999). Prevention of neural-tube defects with folic acid in China. The New England Journal of Medicine, 341, 1485-1490.
6. Birch, E. E., Garfield, S., Hoffmann, D. R., Uauy, R., & Birch, D. G. (2000). A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Developmental Medicine and Child Neurology, 42, 174-181.
7. Blom, H. J., Shaw, G. M., Heijer, M. D., & Finnell, R. H. (2006). Neural tube defects and folate: case far from closed. Nature Reviews Neuroscience, 7, 724-731.
8. Bologa, L., Sharma, J., & Roberts, E. (1987). Dehydroepiandrosterone and its sulfated derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures. Journal of Neuroscience Research, 17, 225-234.
9. Botto, L. D., Moore, C. A., Khoury, M. J., & Erickson, J. D. (1999). Neural tube defects. The New England Journal of Medicine, 341(20), 1509-1519.
10. Carlson, S. E., & Neuringer, M. (1999). Polyunsaturated fatty acid status and neurodevelopment: a summary and critical analysis of the literature. Lipids, 34, 171-178.
11. Craig, A., Sidaway, J., Holmes, E., Orton, T., Jackson, D., Rowlinson, R., et al. (2006). Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat. Journal of Proteome Research, 5, 1586-1601.
12. Czeizel, A. E., & Dudás, I. (1992). Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. The New England Journal of Medicine, 327, 1832-1835.
13. Finnell, R. H., Gould, A., & Spiegelstein, O. (2003). Pathobiology and genetics of neural tube defects. Epilepsia, 44(Suppl. 3), 14-23.
14. Food and Drug Administration. (1996). Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Federal Register, 61(44), 8781-8797.
15. Franke, C., Verwied-Jorky, S., Campoy, C., Trak-Fellermeier, M., Decsi, T., Dolz, V., et al. (2008). Dietary intake of natural sources of docosahexaenoic acid and folate in pregnant women of three European cohorts. Annals of Nutrition and Metabolism, 53, 167-174.
16. Funk, D. C. (2001). Prostaglandins and leukotrienes: advances in eicosanoid biology. Science, 294, 1871-1875.
17. Gu, X., Lin, L. M., Zheng, X. Y., Zhang, T., Song, X. M., Wang, J. F., et al. (2007). High prevalence of NTDs in Shanxi province: a combined epidemiological approach. Birth Defects Research. Part A, Clinical and Molecular Teratology, 79, 702-707.
18. Hait, N. C., Oskeritzian, C. A., Paugh, S. W., & Milstien, S. (2006). Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochimica et Biophysica Acta, 1758(12), 2016-2026.
19. Halliwell, B. (1990). How to characterize a biological antioxidant. Free Radical Research Communications, 9, 1-32.
20. Halliwell, B., Gutteridge, J. M. C., & Cross, C. (1992). Free radicals, antioxidants and human diseases: where are we now? Journal of Laboratory and Clinical Medicine, 119, 598-613.
21. Hernández-Díaz, S., Werler, M. M., Walker, A. M., & Michell, A. A. (2000). Folic acid antagonists during pregnancy and the risk of birth defects. The New England Journal of Medicine, 343, 1608-1614.
22. Hobbs, C. A., Cleves, M. A., Melnyk, S., Zhao, W. Z., & James, S. J. (2005). Congenital heart defects and abnormal maternal biomarkers of methioine and homocysteine metabolism. The American Journal of Clinical Nutrition, 81(1), 147-153.
23. Indrapal, N. S., & Edward, D. H. (2008). Multifaceted roles of sphingosine-1-phosphate: how does this bioactive sphingolipid fit with acute neurological injury? Journal of Neuroscience Research, 86(7), 1419-1433.
24. Ioannis, C., Vassilia-Ismini, A., Iakovos, L., Erene, D., Nicolaos, A., Christos, T., et al. (2006). G protein-associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone. The FASEB Journal, 20, 577-579.
25. Jiang, Z. T., Liang, Q. L., Wang, Y., Zheng, X. Y., Pei, L. J., Zhang, T., et al. (2011). Metabonomic study on women of reproductive age treated with nutitional intervention: screening potential biomarkers related to neural tube defects occurrence. Biomedical Chromatography, 25, 767-774.
26. Koletzko, B., Agostoni, C., Carlson, S. E., Clandinin, T., Hornstra, G., Neuringer, M., et al. (2001). Long chain polyunsaturated fatty acids (LCPUFA) and perinatal development. Acta Paediatrica, 90, 460-464.
27. Kougias, P., Chai, H., Lin, P. H., Lumsden, A. B., Yao, Q., & Chen, C. (2006). Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Medical Science Monitor, 12, RA5-RA16.
28. Li, Z. W., Ren, A., Zhang, L., Guo, Z. L., & Li, Z. (2006). A population-based case-control study of risk factors for neural tube defects in four high-prevalence areas of Shanxi province, China. Paediatric and Perinatal Epidemiology, 20, 43-53.
29. Liang, X. P., Liang, Q. L., Xia, J. F., Wang, Y., Hu, P., Wang, Y. M., et al. (2009). Simultaneous determination of sixteen metabolites related to neural tube defects in maternal serum by liquid chromatography coupling with electrospray tandem mass spectrometry. Talanta, 78, 1246-1252.
30. Mao, X., & Barger, S. W. (1998). Neuroprotection by dehydroepiandrosterone-sulfate: role of an NFkappaB-like factor. Neuroreport, 9, 759-763.
31. Martínez de Villarreal, L. E., Delgado-Enciso, I., Valdéz-Leal, R., Ortíz-López, R., Rojas-Martínez, A., Limón-Benavides, C., et al. (2001). Folate levels and N5, N10-Methylenetetrahydrofolate reductase genotype (MTHFR) in mothers of offspring with neural tube defects: a case-control study. Archives of Medical Research, 32, 277-282.
32. Mills, J. L., McPartlin, J. M., Kirke, P. N., Lee, Y. J., Conley, M. R., Weir, D. G., et al. (1995). Homocysteine metabolism in pregnancies complicated by neural tube defects. The Lancet, 345(8943), 149-151.
33. Milstien, S., & Spiegel, S. (2006). Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics. Cancer Cell, 9(3), 148-150.
34. Mitchell, L. E. (2005). Epidemiology of neural tube defects. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 135C(1), 88-94.
35. Mizugishi, K., Yamashita, T., Olivera, A., Miller, G. F., Spiegel, S., & Proia, R. L. (2005). Essential role for sphingosine kinases in neural and vascular development. Molecular and Cellular Biology, 25(24), 11113-11121.
36. Molloy, A. M., Mills, J. L., Kirke, P. N., Weir, D. G., & Scott, J. M. (1999). Folate status and neural tube defects. Biofactors, 10, 291-294.
37. Olofsson, E. K., Andersson, L., Nilsson, J., & Bjorkbacka, H. (2008). Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages. Biochemical and Biophysical Research Communications, 370, 348-352.
38. Ornoy, A. (2007). Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy. Reproductive Toxicology, 24(1), 31-41.
39. Ousman, S. S., & David, S. (2001). MIP-1a, MCP-1, GM-CSF, and TNF-a control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. The Journal of Neuroscience, 21(13), 4649-4656.
40. Padmanabhan, R. (2006). Etiology, pathogenesis and prevention of neural tube defects. Congenital Anomalies, 46(2), 55-67.
41. Pagano, G., Korkina, L. G., Brunk, U. T., Chessa, L., Degan, P., Del Principe, D., et al. (1998). Congenital disorders sharing oxidative stress and cancer proneness as phenotypic hallmarks: prospects for joint research in pharmacology. Medical Hypotheses, 51, 253-266.
42. Pang, L. Q., Liang, Q. L., Wang, Y. M., Li, P., & Luo, G. A. (2008). Simultaneous determination and quantification of seven major phospholipid classes in human blood using normal-phase liquid chromatography coupled with electrospray mass spectrometry and the application in diabetes nephropathy. Journal of Chromatography B, 869, 118-125.
43. Parker, L., Pearce, M. S., Dickinson, H. O., Aitkin, M., & Craft, A. W. (1999). Stillbirths among offspring of male radiation workers at Sellafield nuclear reprocessing plant. The Lancet, 354(9188), 1407-1414.
44. Paruchuri, S., Broom, O., Dib, K., & Sjolander, A. (2005). The pro-inflammatory mediator leukotriene D4 induces phosphatidylinositol 3-kinase and rac-dependent migration of intestinal epithelial cells. The Journal of Biological Chemistry, 280, 13538-13544.
45. Peeters, M. C. E., Hekking, J. W. M., van Straaten, H. W. M., Shum, A. S. W., & Copp, A. J. (1996). Relationship between altered axial curvature and neural tube closure in normal and mutant (curly tail) mouse embryos. Anatomy and Embryology, 193(2), 123-130.
46. Philippe, G., Malcolm, I. V. J., Jean-Pierre, V., & Anthony, J. F. (1998). The role of inflammation in disk herniation-associated radiculopathy. Seminars in Arthritis and Rheumatism, 28, 60-71.
47. Pischon, T., Hankinson, E. S., Hotamisligil, S. G., Rifai, N., Willett, C. W., & Rimm, B. E. (2003). Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation, 108, 155-160.
48. Psihogios, N. G., Kalaitzidis, R. G., Dimou, S., Seferiadis, K. I., Siamopoulos, K. C., & Bairaltari, E. T. (2007). Evaluation of tubulointerstitial lesions' severity in with glomerulonephritides: an NMR-based metabonomic study. Journal of Proteome Research, 6, 3760-3770.
49. Saldeen, P., & Saldeen, T. (2004). Women and omega-3 fatty acids. Obstetrical and Gynecological Survey, 95, 722-730.
50. Scholz, J., & Woolf, J. C. (2007). The neuropathic pain trias: neurons, immune cells and glia. Nature Neuroscience, 10, 1361-1368.
51. U. S. Department of Health and Human Services Public Health Service Centers for Disease Control. (1992). Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. http://www. cdc. gov/mmwr/preview/mmwrhtml/00019479. htm.
52. van der Put, N. M., Steegers-Theunissen, R. P., Frosst, P., Trijbels, F. J., Eskes, T. K., van der Heuvel, L. P., et al. (1995). Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. The Lancet, 346, 1070-1071.
53. Wald, N., & Sneddon, J. (1991). Prevention of neural tube defects: results of the medical research council vitamin study. The Lancet, 338, 131-137.
54. Wang, Y., Zhang, H. Y., Liang, Q. L., Yang, H. H., Wang, Y. M., Liu, Q. F., et al. (2008). Simultaneous quantification of 11 pivotal metabolites in neural tube defects by HPLC-electrospray tandem mass spectrometry. Journal of Chromatography B, 863, 94-100.
55. Werscha, J. W. J., Janssensb, Y., & Zandvoort, J. A. (2002). Folic acid, vitamin B12, and homocysteine in smoking and non-smoking pregnant women. European Journal of Obstetrics & Gynecology and Reproductive Biology, 103(1), 18-21.
56. Yang, J., Zhao, X. J., Liu, X. L., Wang, C., Gao, P., Wang, J. S., et al. (2006). High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B. Journal of Proteome Research, 5, 554-561.
57. Yap, I. K. S., Clayton, T. A., Tang, H. R., Everett, J. R., Hanton, G., Provost, J. P., et al. (2006). An integrated metabonomic approach to describe temporal metabolic disregulation induced in the rat by the model hepatotoxin allyl formate. Journal of Proteome Research, 5, 2675-2684.
58. +/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxidants & Redox Signaling, 10(2), 179-206.
59. Yu, K., Sheng, G. P., Sheng, J. F., Chen, Y. M., Xu, W., Liu, X. L., et al. (2007). A metabonomic investigation on the biochemical perturbation in liver failure caused by hepatitis B virus. Journal of Proteome Research, 6, 2413-2419.
60. Zalewski, A., & Macphee, C. (2005). Role of lipoprotein-associated phospholopase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target. Arteriosclerosis Thrombosis and Vascular Biology, 25, 923-931.
61. Zhang, L., Li, B. S., Ma, W., Barker, J. L., Chang, Y. H., Zhao, W. Q., et al. (2002). Dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signaling pathway in opposing ways. Molecular Brain Research, 98, 58-66.
62. Zhang, H. Y., Luo, G. A., Liang, Q. L., Wang, Y., Yang, H. H., Wang, Y. M., et al. (2008). Neural tube defects and disturbed maternal folate- and homocysteine-mediated one-carbon metabolism. Experimental Neurology, 212(2), 515-521.
63. Zhu, H., Wicker, N. J., Shaw, G. M., Lammer, E. J., Hendricks, K., Suarez, L., et al. (2003). Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Molecular Genetics and Metabolism, 78, 216-221.